Annarita Nappi

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

Fortunato Ciardiello, Nicola Normanno, Erika Martinelli et al. · Annals of Oncology · 2016 · 98 citations

Medicine, Oncology, Pharmacotherapy +11

Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer

Caterina Miro, A Giovanni, Melania Murolo et al. · Cancer Letters · 2022 · 74 citations

Medicine, Endocrinology, Oncology +17

Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch

Caterina Miro, Emery Di Cicco, Raffaele Ambrosio et al. · Nature Communications · 2019 · 66 citations · Full text

Medicine, Cancer Biology, Oncology +17

The thyroid hormone activating enzyme, type 2 deiodinase, induces myogenic differentiation by regulating mitochondrial metabolism and reducing oxidative stress

Serena Sagliocchi, Annunziata Gaetana Cicatiello, Emery Di Cicco et al. · Redox Biology · 2019 · 59 citations · Full text

Life Sciences, Endocrinology, Physiology +17

AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer

Claudia Cardone, Bernadette Blauensteiner, Verónica Moreno‐Viedma et al. · European Journal of Cancer · 2020 · 49 citations

Medicine, Cancer Biology, Oncology +16